1 min read podcast

MindMed Deep Dive

MindMed Deep Dive

Many of us have already 10x'd our money on MindMedicine (MMED / MMEDF): should we take our profits now or hold for the next 10 years? Brom dives deep into this topic and looks at questions like:

  • Will the Nasdaq uplisting happen?
  • Is MindMed's drug development pipeline strong?
  • Why is MindMed associated with sketchy pump and dump groups like Departures Capital and Market Jar Media?
  • Do they have a way to capitalize on their research?
  • WTF is Kevin O'Leary doing in a psychedelics company?
  • Why did JR Rahn sell his shares?
  • Does MindMed Founder and CEO JR Rahn have the right qualifications?
  • Is MindMed's team a winning team?

You might also like...

Sep
19
10 Psychedelic Startup Ideas | Request for Psychedelic Startups

10 Psychedelic Startup Ideas | Request for Psychedelic Startups

Brom discusses 10 interesting startup ideas for entrepreneurs in the psychedelics space. The ideas include applications of psychedelics to non
Sep
19
Chad Conner and Patrick Eckstrom of Mycrodose Therapeutics

Chad Conner and Patrick Eckstrom of Mycrodose Therapeutics

Mycrodose Therapeutics is a US-Based pharmaceutical company specializing in the development of Advanced Drug Delivery (ADD) systems for psychedelic compounds.
Sep
19
Richard Skaife of The Conscious Fund

Richard Skaife of The Conscious Fund

Richard Skaife is a cofounder of The Conscious Fund, one of the leading Venture Capital funds focused on psychedelic medicine,
Sep
19
Todd Shapiro of Red Light Holland

Todd Shapiro of Red Light Holland

Todd Shapiro is the CEO of Red Light Holland ($TRIP, $TRUFF), the only publicly traded company focused on recreational psychedelics.
1 min read
Sep
19
Brom Tries Psychedelic VR

Brom Tries Psychedelic VR

Lyle Maxson is the co-founder of https://www.entheo.digital/ , a virtual reality / digital therapeutic company creating "technodelic" experiences that